Leadership

Board of Trustees

Salk Institute for Biological Studies - Leadership - Board of Trustees

Board of Trustees


The Board of Trustees is composed of proven leaders from the world’s business and non-profit communities who bring a range of skills and perspectives to the Institute. They are committed to science, innovation, high-quality research and supporting the Institute’s mission. Trustees are charged with monitoring Institute operations to ensure the organization fulfills its scientific and training efforts, while operating in a financially responsible manner.

Marna C. Whittington, PhD (Chair)

(Retired) Chief Executive Officer

Allianz Global Investors Capital
Delaware

Richard A. Heyman, PhD (Vice Chair)

Salk Alumnus
Executive Chairman

Metacrine
California

Markus Reinhard (Vice Chair)

Managing Director

NOMIS Foundation
Switzerland

David Dolby

Director

Dolby Family Ventures, LP
California

Frederick J. Dotzler

Managing Director

De Novo Ventures
California

Dennis Driver

(Retired) Senior Vice President

Theravance Biopharma, Inc.
California

Jay Flatley

(Former) Executive Chairman

Illumina
California

Rusty Gage, PhD

President

Laboratory of Genetics
Vi and John Adler Chair for Research on Age-Related Neurodegenerative Disease
Salk Institute
California

Carol Gallagher, PharmD

Venture Partner

New Enterprise Associates
California

Alan D. Gold

Executive Chairman

Innovative Industrial Properties, IQHQ
Utah

Martyn Goulding, PhD

Professor

Molecular Neurobiology Laboratory
Frederick W. and Joanna J. Mitchell Chair
Salk Institute
California

Edwin K. Hunter

Trustee

Joe W. and Dorothy Dorsett Brown Foundation
Louisiana/Utah

Lyn Hutton

Investment Consultant

California

Irwin Mark Jacobs, ScD (Chair Emeritus)

Founding Chairman and CEO Emeritus

QUALCOMM Incorporated
California

Sanjay K. Jha, PhD

Partner

Eclipse Ventures
California

Mark Knickrehm

Former Group Chief Executive

Accenture Strategy
California

Benjamin H. Lewis, MD

Columbia University Medical Center
New York Presbyterian Hospital
New York

Daniel C. Lewis

Former President

Booz Allen Hamilton
California

Corinne Mentzelopoulos

Chairman and Chief Executive Officer

Ch√Ęteau Margaux
France

Howard H. Newman, PhD

Chairman and CEO

Pine Brook Road Partners, LLC
New York

Frederik Paulsen, PhD

Chairman

Ferring International Center S. A.
Switzerland

Terry Rosen, PhD

Co-founder and CEO

Arcus Biosciences
California

Eric Sagerman

Strategic Advisor

California

Mary Jane Salk

Author and philanthropist

New York

Timothy M. Schoen

President and CEO

BioMed Realty
California

Tatyana Sharpee, PhD

Professor

Computational Neurobiology Laboratory
Edwin K. Hunter Chair
Salk Institute
California

Reuben Shaw, PhD

Professor

Molecular and Cell Biology Laboratory
William R. Brody Chair
Salk Institute
California

Haeyoung Kong Tang, PhD

Philanthropist

California

Daniel Tierney

President

Wicklow Capital Inc.
Illinois

Irving Weissman, MD

Professor

Virginia and D.K. Ludwig Professor for Clinical Investigation in Cancer Research
Professor of Developmental Biology
Stanford University
California